United Kingdom· GB-APID-44312011000001106
Dovprela 200mg tablets
A pretomanid product containing pretomanid, registered in United Kingdom by Imported (Italy). The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pretomanid is registered in 10 of 19 countries.
Countries holding a registration under ATC J04AK08 (pretomanid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Pretomanid · ATC J04AK08
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pretomanid
- Manufacturer
- Imported (Italy)
- Country
- United Kingdom (GB)
- ATC code
- J04AK08
- ATC class
- Pretomanid
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for pretomanid.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pretomanid · interactions on record
20 records
- 9 severe
- 11 moderate
Most severe, free to view
- DexamethasoneH02AB02severe
- DabrafenibL01EC02severe
- LorlatinibL01ED05severe
- DabrafenibL01XE23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pretomanid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVPRELAMylan IRE Healthcare Limited, Dublin
- FinlandDovprelaMylan IRE Healthcare Limited
- FranceDOVPRELA 200 mg, compriméMYLAN IRE HEALTHCARE (IRLANDE)
- IrelandDovprela 200 mg tabletsMylan IRE Healthcare Limited
- IcelandDovprelaMylan IRE Healthcare Limited
- NetherlandsDovprela 200 mg tabletMylan IRE Healthcare Limited
- NorwayDovprelaMylan
- PolandDovprelaMylan IRE Healthcare Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dovprela
- Liechtenstein · Dovprela
- Norway · Dovprela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b6f8d40-2034-46a5-9310-38a2c44abbb6 GET /v1/drugs/4b6f8d40-2034-46a5-9310-38a2c44abbb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44312011000001106",
"desc": "Dovprela 200mg tablets (Imported (Italy))",
"form": "Oral tablet",
"vpid": "44430111000001106",
"source": "dmd",
"vtm_id": "789322001",
"strength": "200 mg",
"substance": "Pretomanid",
"ingredient": "Pretomanid",
"supplier_code": "11820911000001107"
}See everything about pretomanid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.